Antioxidant and vascular protective effects of curcumin and tetrahydrocurcumin in rats with L-NAME-induced hypertension

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 383, Issue 5, 2011, Pages 519-529

  Nakmareong, Saowanee ^a   Kukongviriyapan, Upa ^a   Pakdeechote, Poungrat ^a   Donpunha, Wanida ^a   Kukongviriyapan, Veerapol ^a   Kongyingyoes, Bunkerd ^a   Sompamit, Kwanjit ^b   Phisalaphong, Chada ^c  

^a KHON KAEN UNIVERSITY   (Thailand)

^b MAHASARAKHAM UNIVERSITY   (Thailand)

^c Thailand Government Pharmaceutical Organization   (Thailand)

Author keywords

Curcumin; L NAME hypertension; Nitric oxide; Oxidative stress; Tetrahydrocurcumin; Vascular dysfunction

Indexed keywords

ACETYLCHOLINE; ANGIOTENSIN II; CURCUMIN; DRUG METABOLITE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTATHIONE; N(G) NITROARGININE METHYL ESTER; NITRATE; NITRITE; SUPEROXIDE; TETRAHYDROCURCUMIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ANTIOXIDANT ACTIVITY; AORTA; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; HEART HEMODYNAMICS; HYPERTENSION; MALE; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; VASCULAR RESISTANCE;

ANIMALS; ANTIOXIDANTS; BLOOD PRESSURE; BLOTTING, WESTERN; CURCUMIN; GLUTATHIONE; HYPERTENSION; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; PROTEIN CARBONYLATION; RATS; RATS, SPRAGUE-DAWLEY; VASCULAR RESISTANCE;

EID: 79955694427     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-011-0624-z     Document Type: Article

References (46)

1. Aggarwal BB, Sung B (2009) Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol Sci 30:85-94
2. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB (2007) Bioavailability of curcumin: problems and promises. Mol Pharm 4:807-818
3. Arnal JF, Warin L, Michel JB (1992) Determinants of aortic cyclic guanosine monophosphate in hypertension induced by chronic inhibition of nitric oxide synthase. J Clin Invest 90:647-652
4. Baylis C, Mitruka B, Deng A (1992) Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest 90:278-281
5. Bengmark S (2006) Curcumin, an atoxic antioxidant and natural NFkappaB, cyclooxygenase-2, lipooxygenase, and inducible nitric oxide synthase inhibitor: a shield against acute and chronic diseases. JPEN J Parenter Enteral Nutr 30:45-51
6. Bredt DS, Snyder SH (1994) Nitric oxide: a physiologic messenger molecule. Annu Rev Biochem 63:175-195
7. Cai H, Harrison DG (2000) Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87:840-844
8. De Gennaro CV, Rossoni G, Rigamonti A, Bonomo S, Manfredi B, Berti F, Muller E (2002) Enalapril and quinapril improve endothelial vasodilator function and aortic eNOS gene expression in L-NAME-treated rats. Eur J Pharmacol 450:61-66
9. De Gennaro CV, Rigamonti A, Fioretti S, Bonomo S, Manfredi B, Ferrario P, Bianchi M, Berti F, Muller EE, Rossoni G (2005) Angiotensin-converting enzyme inhibition and angiotensin AT1- receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats. Eur J Pharmacol 516:253-259 (Pubitemid 40922746)
10. Dinkova-Kostova AT, Talalay P (2008) Direct and indirect antioxidant properties of inducers of cytoprotective proteins. Mol Nutr Food Res 52(Suppl 1):S128-S138
11. Farombi EO, Shrotriya S, Na HK, Kim SH, Surh YJ (2008) Curcumin attenuates dimethylnitrosamine-induced liver injury in rats through Nrf2-mediated induction of heme oxygenase-1. Food Chem Toxicol 46:1279-1287 (Pubitemid 351258204)
12. Ferroni P, Basili S, Paoletti V, Davi G (2006) Endothelial dysfunction and oxidative stress in arterial hypertension. Nutr Metab Cardiovasc Dis 16:222-233
13. Heiss EH, Schachner D, Werner ER, Dirsch VM (2009) Active NF-E2-related factor (Nrf2) contributes to keep endothelial NO synthase (eNOS) in the coupled state: role of reactive oxygen species (ROS), eNOS, and heme oxygenase (HO-1) levels. J Biol Chem 284:31579-31586
14. Henrion D, Dowell FJ, Levy BI, Michel JB (1996) In vitro alteration of aortic vascular reactivity in hypertension induced by chronic NG-nitro-L-arginine methyl ester. Hypertension 28:361-366
15. Ireson CR, Jones DJ, Orr S, Coughtrie MW, Boocock DJ, Williams ML, Farmer PB, Steward WP, Gescher AJ (2002) Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer Epidemiol Biomark Prev 11:105-111 (Pubitemid 34118319)
16. Kawazoe T, Kosaka H, Yoneyama H, Hata Y (2000) Acute production of vascular superoxide by angiotensin II but not by catecholamines. J Hypertens 18:179-185 (Pubitemid 30114064)
17. Kitamoto S, Egashira K, Kataoka C, Usui M, Koyanagi M, Takemoto M, Takeshita A (2000) Chronic inhibition of nitric oxide synthesis in rats increases aortic superoxide anion production via the action of angiotensin II. J Hypertens 18:1795-1800
18. Kukongviriyapan V, Somparn N, Senggunprai L, Prawan A, Kukongviriyapan U, Jetsrisuparb A (2008) Endothelial dysfunction and oxidant status in pediatric patients with hemoglobin E-beta thalassemia. Pediatr Cardiol 29:130-135
19. Luangaram S, Kukongviriyapan U, Pakdeechote P, Kukongviriyapan V, Pannangpetch P (2007) Protective effects of quercetin against phenylhydrazine-induced vascular dysfunction and oxidative stress in rats. Food Chem Toxicol 45:448-455 (Pubitemid 46176370)
20. Manning RD Jr, Hu L, Mizelle HL, Montani JP, Norton MW (1993) Cardiovascular responses to long-term blockade of nitric oxide synthesis. Hypertension 22:40-48 (Pubitemid 23187381)
21. Moncada S, Higgs EA (1991) Endogenous nitric oxide: physiology, pathology and clinical relevance. Eur J Clin Investig 21:361-374
22. Motterlini R, Foresti R, Bassi R, Green CJ (2000) Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress. Free Radic Biol Med 28:1303-1312 (Pubitemid 30417475)
23. Mukai Y, Sato S (2009) Polyphenol-containing azuki bean (Vigna angularis) extract attenuates blood pressure elevation and modulates nitric oxide synthase and caveolin-1 expressions in rats with hypertension. Nutr Metab Cardiovasc Dis 19:491-497
24. Murakami Y, Ishii H, Takada N, Tanaka S, Machino M, Ito S, Fujisawa S (2008) Comparative anti-inflammatory activities of curcumin and tetrahydrocurcumin based on the phenolic O-H bond dissociation enthalpy, ionization potential and quantum chemical descriptor. Anticancer Res 28:699-707 (Pubitemid 351578911)
25. Murugan P, Pari L (2007) Influence of tetrahydrocurcumin on erythrocyte membrane bound enzymes and antioxidant status in experimental type 2 diabetic rats. J Ethnopharmacol 113:479-486 (Pubitemid 47361566)
26. Okada K, Wangpoengtrakul C, Tanaka T, Toyokuni S, Uchida K, Osawa T (2001) Curcumin and especially tetrahydrocurcumin ameliorate oxidative stress-induced renal injury in mice. J Nutr 131:2090-2095 (Pubitemid 32720635)
27. Pae HO, Jeong GS, Jeong SO, Kim HS, Kim SA, Kim YC, Yoo SJ, Kim HD, Chung HT (2007) Roles of heme oxygenase-1 in curcumin-induced growth inhibition in rat smooth muscle cells. Exp Mol Med 39:267-277
28. Pari L, Amali DR (2005) Protective role of tetrahydrocurcumin (THC) an active principle of turmeric on chloroquine induced hepatotoxicity in rats. J Pharm Pharm Sci 8:115-123 (Pubitemid 41528877)
29. Pechanova O, Bernatova I, Babal P, Martinez MC, Kysela S, Stvrtina S, Andriantsitohaina R (2004) Red wine polyphenols prevent cardiovascular alterations in L-NAME-induced hypertension. J Hypertens 22:1551-1559 (Pubitemid 39037607)
30. Priviero FB, Teixeira CE, Claudino MA, De Nucci G, Zanesco A, Antunes E (2007) Vascular effects of long-term propranolol administration after chronic nitric oxide blockade. Eur J Pharmacol 571:189-196 (Pubitemid 47379687)
31. Ramaswami G, Chai H, Yao Q, Lin PH, Lumsden AB, Chen C (2004) Curcumin blocks homocysteine-induced endothelial dysfunction in porcine coronary arteries. J Vasc Surg 40:1216-1222 (Pubitemid 40037290)
32. Ravindranath V, Chandrasekhara N (1981) Metabolism of curcumin-studies with [3H]curcumin. Toxicology 22:337-344
33. Rinwa P, Kaur B, Jaggi AS, Singh N (2010) Involvement of PPAR-gamma in curcumin-mediated beneficial effects in experimental dementia. Naunyn Schmiedebergs Arch Pharmacol 381:529-539
34. Rungseesantivanon S, Thenchaisri N, Ruangvejvorachai P, Patumraj S (2010) Curcumin supplementation could improve diabetes-induced endothelial dysfunction associated with decreased vascular superoxide production and PKC inhibition. BMC Complement Altern Med 10:1-9
35. Sharma RA, Gescher AJ, Steward WP (2005) Curcumin: the story so far. Eur J Cancer 41:1955-1968 (Pubitemid 41557681)
36. Simko F, Pechanova O, Pelouch V, Krajcirovicova K, Celec P, Palffy R, Bednarova K, Vrankova S, Adamcova M, Paulis L (2010) Continuous light and L-NAME-induced left ventricular remodelling: different protection with melatonin and captopril. J Hypertens 28(Suppl 1):S13-S18
37. Sompamit K, Kukongviriyapan U, Nakmareong S, Pannangpetch P, Kukongviriyapan V (2009) Curcumin improves vascular function and alleviates oxidative stress in non-lethal lipopolysaccharide-induced endotoxaemia in mice. Eur J Pharmacol 616:192-199
38. Somparn P, Phisalaphong C, Nakornchai S, Unchern S, Morales NP (2007) Comparative antioxidant activities of curcumin and its demethoxy and hydrogenated derivatives. Biol Pharm Bull 30:74-78 (Pubitemid 46066323)
39. Sugiyama Y, Kawakishi S, Osawa T (1996) Involvement of the beta-diketone moiety in the antioxidative mechanism of tetrahydrocurcumin. Biochem Pharmacol 52:519-525 (Pubitemid 26253384)
40. Suphim B, Prawan A, Kukongviriyapan U, Kongpetch S, Buranrat B, Kukongviriyapan V (2010) Redox modulation and human bile duct cancer inhibition by curcumin. Food Chem Toxicol 48:2265-2272
41. Tanwar V, Sachdeva J, Golechha M, Kumari S, Arya DS (2010) Curcumin protects rat myocardium against isoproterenol-induced ischemic injury: attenuation of ventricular dysfunction through increased expression of Hsp27 along with strengthening antioxidant defense system. J Cardiovasc Pharmacol 55:377-384
42. Tietze F (1969) Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem 27:502-522
43. Tsukahara H, Hiraoka M, Kobata R, Hata I, Ohshima Y, Jiang MZ, Noiri E, Mayumi M (2000) Increased oxidative stress in rats with chronic nitric oxide depletion: measurement of urinary 8-hydroxy-2′-deoxyguanosine excretion. Redox Rep 5:23-28 (Pubitemid 30389532)
44. Usui M, Egashira K, Kitamoto S, Koyanagi M, Katoh M, Kataoka C, Shimokawa H, Takeshita A (1999) Pathogenic role of oxidative stress in vascular angiotensin-converting enzyme activation in long-term blockade of nitric oxide synthesis in rats. Hypertension 34:546-551 (Pubitemid 29496431)
45. Xu PH, Long Y, Dai F, Liu ZL (2007) The relaxant effect of curcumin on porcine coronary arterial ring segments. Vascul Pharmacol 47:25-30 (Pubitemid 46818134)
46. Zalba G, San Jose G, Moreno MU, Fortuno MA, Fortuno A, Beaumont FJ, Diez J (2001) Oxidative stress in arterial hypertension: role of NAD(P)H oxidase. Hypertension 38:1395-1399 (Pubitemid 34033422)